Dr. Edward Alexander McGillicuddy, MD

Dr. McGillicuddy practices at Alfond Center for Health in Augusta, Maine.

Dr. McGillicuddy's NPI, 1548593270, was assigned on September 14, 2009. Dr. McGillicuddy graduated from Vanderbilt University School of Medicine in 2006. Dr. McGillicuddy holds Maine license MD20615.

Dr. McGillicuddy's primary practice is Alfond Center for Health, at 35 Medical Center Pkwy, Augusta, ME 04330 in Kennebec County. The practice phone is (207) 873-9841.

Dr. McGillicuddy's primary practice is Alfond Center for Health in Augusta, Maine. Dr. McGillicuddy is also affiliated with MaineGeneral Medical Center. The medical group on file is MaineGeneral Health. Dmand AI also links Dr. McGillicuddy to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McGillicuddy practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. McGillicuddy's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. McGillicuddy is licensed in Maine.

CMS data shows 694 Medicare services from Dr. McGillicuddy across 17 procedure codes in 2024, for 268 Medicare patients. Medicare paid $26,280 for them.

CMS counts 268 Medicare patients who saw Dr. McGillicuddy in 2024. The largest group is 65 to 74, with 101 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McGillicuddy's median patient age at 72, with 49% women.

In 2024, Dr. McGillicuddy wrote 268 Medicare Part D claims for 104 patients. 92% of them were for generic drugs. CMS names the drug for 213 of them, across 5 drugs with 11 or more claims each, at $30,761 in total drug cost. In 2023, CMS named 179 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. McGillicuddy for performance year 2024, reported as part of a group. Dr. McGillicuddy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of leg revascularization (restoring blood flow) by Dr. McGillicuddy, more than 64% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Dr. McGillicuddy, published from 2011 to 2016. 2011 was the busiest year, with 3. The most frequent topics are Tomography, X-Ray Computed, Algorithms and Anti-Bacterial Agents. Dr. McGillicuddy has published most often in J Trauma. Dr. McGillicuddy's most frequent co-authors are Kimberly A. Davis, MD, Kevin Michael Schuster, MD and Michael Belkin, MD.

CMS Open Payments shows 43 general payments to Dr. McGillicuddy from 16 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 65% of the total. Silk Road Medical, Inc. paid the most, $2,210.

Dr. McGillicuddy graduated from Vanderbilt University School of Medicine in 2006.